Daily close, T-120 (9/9/25) through T+5. Run-up high $52.34 on 11/20/25, low $45.07 on 10/2/25 (T-120 to T-1). FDA decision 2/24/26. Historical price action, not a forecast.
Yes. The FDA approved the application for primary-sourced on February 24, 2026. The primary source is linked on this page.
How did SNY stock react to the FDA decision?
On the decision day SNY moved +0.2%. That is the recorded reaction to this specific event -- historical measurement, not a prediction, and not investment advice.